TITLE

Pharmacy groups on warpath over AMP

AUTHOR(S)
Paul, Reid
PUB. DATE
July 2007
SOURCE
Drug Topics;7/23/2007, Vol. 151 Issue 14, p10
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article reports that the U.S. Centers for Medicare & Medicaid Services' (CMS) release of the final version of its average manufacturer price (AMP) rule has received universal disapproval from pharmacy organizations. The rule implements one of the elements of the Deficit Reduction Act of 2005, mandating CMS to begin to calculate federal upper limits for generic drug reimbursement in the Medicaid program based on AMP data. Comments from National Association of Chain Drug Stores president and chief executive officer (CEO) Steven C. Anderson and the American Pharmacists Association are presented.
ACCESSION #
26131615

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics